| 发明名称 |
Probiotic derived non-viable material for infection prevention and treatment |
| 摘要 |
A composition comprising a culture supernatant from a late-exponential growth phase of a batch-cultivation process for a probiotic such as LGG, for use in the treatment or prevention of infection by a pathogen such as C. |
| 申请公布号 |
AU2013235365(B2) |
申请公布日期 |
2016.05.19 |
| 申请号 |
AU20130235365 |
申请日期 |
2013.03.18 |
| 申请人 |
MJN U.S. HOLDINGS LLC |
发明人 |
VAN TOL, ERIC A. F.;GROSS, GABRIELE;BRAAKSMA, MACHTELT;OVERKAMP, KARIN M.;POELS, EDUARD K. |
| 分类号 |
A61K35/74;C12R1/225 |
主分类号 |
A61K35/74 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
